Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Elevidyselevidyshcp.comELEVIDYS is a one-time AAV-based gene therapy indicated for ambulatory patients aged 4 years and older with Duchenne muscular dystrophy who have a confirmed DMD gene mutation. It enables expression of functional micro-dystrophin and is administered at over 70 treatment centers nationwide, with support for patients and providers before, during, and after treatment.
Parse Score
